The Porter Law Group has presented a substantial settlement demand of $43.5 million in a medical malpractice case involving the alleged mishandling of a concerning PSA test result that led to a delayed prostate cancer diagnosis. The case highlights the devastating consequences of missed opportunities for early detection and intervention in cancer diagnosis.
Contact us to understand your legal options (free consultation).
The case centers around a 40-year-old patient who received a PSA test result of 3.88 ng/mL in December 2018, a value significantly higher than normal for his age group. According to the legal documentation, both a physician assistant and a physician failed to take appropriate action when presented with these concerning results, despite the test value being a potential indicator of prostate cancer.
The medical providers’ alleged failures included not engaging in proper shared decision-making with the patient, not adequately educating him about the implications of his abnormal PSA result, failing to refer him to a urologist, and not ordering timely follow-up testing. These oversights resulted in a critical delay in diagnosis, with the patient ultimately receiving a terminal cancer diagnosis in July 2020.
The case presents compelling evidence of the healthcare providers’ deviation from the standard of care. According to expert testimony, the standard of care required the medical providers to presume the elevated PSA level was concerning for prostate cancer until proven otherwise, thoroughly educate the patient about the potential consequences, outline all available treatment options, and offer a referral to a urologist for specialized care.
The economic impact of this medical negligence is substantial. The patient, a successful executive who had risen through the corporate ranks, faces a premature end to his career and life. Economic analysis indicates that his future lost earnings, including salary and corporate options, could exceed $78 million before being reduced to present value. The settlement demand takes into account not only these economic losses but also the profound impact on the patient’s quality of life and his family’s future.
The patient’s professional trajectory demonstrates the magnitude of the financial impact. Having advanced from a Field Trainer to Vice President of Sales, he was on track for further promotion and significant equity compensation through anticipated corporate sales. Due to his declining health, he was unable to accept a promotion to President, which would have provided substantial additional compensation and benefits.
The case underscores the critical importance of proper PSA test result interpretation and timely follow-up in primary care settings. According to medical experts, when a man in his forties presents with an elevated PSA level, healthcare providers must take prompt action to rule out prostate cancer through appropriate referrals and repeat testing.
The Porter Law Group has compiled extensive documentation supporting the claim, including employment agreements, option agreements, and detailed economic loss calculations. The economic expert’s analysis projects losses extending through what would have been the patient’s expected retirement age of 65, accounting for both direct salary losses and missed opportunities for equity compensation.
For individuals facing similar situations involving potential medical negligence, this case serves as a crucial reminder of the importance of seeking legal counsel when healthcare providers fail to properly address concerning test results. The Porter Law Group continues to advocate for patients who have suffered devastating consequences due to medical negligence and delayed cancer diagnoses.
If you or a loved one has experienced a delayed cancer diagnosis or other serious medical error, it’s essential to seek experienced legal representation to protect your rights and future security. Medical malpractice cases require specialized knowledge and expertise to navigate successfully, and time limitations apply for filing claims.
